2006 ICD-9-CM Volume 1 Diagnosis Codes Home > Certain Conditions Originating In The Perinatal Period 760-779 > Maternal Causes Of Perinatal Morbidity And Mortality 760-763 > Fetus Or Newborn Affected By Maternal Conditions Which May Be Unrelated To Present Pregnancy 760.* > 2006 ICD-9-CM Diagnosis 760.70 Noxious influences affecting fetus or newborn via placenta or breast milk, unspecified noxious substance View the most recent version of ICD-9-CM 760.70 760.70 is a specific code that can be used to specify a diagnosis 760.70 contains 10 index entries View the ICD-9-CM Volume 1 760.* hierarchy Alternate Terminology Fetus or newborn affected by: Drug NEC  Index entries containing 760.70: Absorption chemical NEC 989.9 through placenta or breast milk (fetus or newborn) 760.70 alcohol 760.71 anticonvulsants 760.77 antifungals 760.74 anti-infective agents 760.74 antimetabolics 760.78 cocaine 760.75 "crack" 760.75 diethylstilbestrol [DES] 760.76 hallucinogenic agents 760.73 medicinal agents NEC 760.79 narcotics 760.72 obstetric anesthetic or analgesic drug 763.5 specified agent NEC 760.79 suspected, affecting management of pregnancy 655.5 drug NEC (see also Reaction, drug) through placenta or breast milk (fetus or newborn) 760.70 alcohol 760.71 anticonvulsants 760.77 antifungals 760.74 anti-infective agents 760.74 antimetabolics 760.78 cocaine 760.75 "crack" 760.75 diethylstilbestrol (DES) 760.76 hallucinogenic agents 760.73 medicinal agents NEC 760.79 narcotics 760.72 obstetric anesthetic or analgesic drug 763.5 specified agent NEC 760.79 suspected, affecting management of pregnancy 655.5 Intoxication chemical - see also Table of Drugs and Chemicals via placenta or breast milk 760.70 alcohol 760.71 anticonvulsants 760.77 antifungals 760.74 anti-infective agents 760.74 antimetabolics 760.78 cocaine 760.75 "crack" 760.75 hallucinogenic agents NEC 760.73 medicinal agents NEC 760.79 narcotics 760.72 obstetric anesthetic or analgesic drug 763.5 specified agent NEC 760.79 suspected, affecting management of pregnancy 655.5 drug 292.89 via placenta or breast milk 760.70 alcohol 760.71 anticonvulsants 760.77 antifungals 760.74 anti-infective agents 760.74 antimetabolics 760.78 cocaine 760.75 "crack" 760.75 hallucinogenic agents 760.73 medicinal agents NEC 760.79 narcotics 760.72 obstetric anesthetic or analgesic drug 763.5 specified agent NEC 760.79 suspected, affecting management of pregnancy 655.5 fetus or newborn, via placenta or breast milk 760.70 alcohol 760.71 anticonvulsants 760.77 antifungals 760.74 anti-infective agents 760.74 antimetabolics 760.78 cocaine 760.75 "crack" 760.75 hallucinogenic agents 760.73 medicinal agents NEC 760.79 narcotics 760.72 obstetric anesthetic or analgesic drug 763.5 specified agent NEC 760.79 suspected, affecting management of pregnancy 655.5 Maternal condition, affecting fetus or newborn noxious substance transmitted via breast milk or placenta 760.70 alcohol 760.71 anticonvulsants 760.77 antifungals 760.74 anti-infective agents 760.74 antimetabolics 760.78 cocaine 760.75 "crack" 760.75 diethylstilbestrol [DES] 760.76 hallucinogenic agents 760.73 medicinal agents NEC 760.79 narcotics 760.72 obstetric anesthetic or analgesic drug 760.72 specified agent NEC 760.79 transmission of chemical substance through the placenta 760.70 alcohol 760.71 anticonvulsants 760.77 antifungals 760.74 anti-infective 760.74 antimetabolics 760.78 cocaine 760.75 "crack" 760.75 diethylstilbestrol [DES] 760.76 hallucinogenic agents 760.73 narcotics 760.72 specified substance NEC 760.79 Newborn (infant) (liveborn) affected by maternal abuse of drugs (gestational) (via placenta) (via breast milk) (see also Noxious, substances transmitted through placenta or breast milk (affecting fetus or newborn)) 760.70 Noxious substances transmitted through placenta or breast milk (affecting fetus or newborn) 760.70 acetretin 760.78 alcohol 760.71 aminopterin 760.78 antiandrogens 760.79 anticonvulsant 760.77 antifungal 760.74 anti-infective agents 760.74 antimetabolic 760.78 atorvastatin 760.78 carbamazepine 760.77 cocaine 760.75 "crack" 760.75 diethylstilbestrol (DES) 760.76 divalproex sodium 760.77 endocrine disrupting chemicals 760.79 estrogens 760.79 etretinate 760.78 fluconazole 760.74 fluvastatin 760.78 hallucinogenic agents NEC 760.73 hormones 760.79 lithium 760.79 lovastatin 760.78 medicinal agents NEC 760.79 methotrexate 760.78 misoprostil 760.79 narcotics 760.72 obstetric anesthetic or analgesic 763.5 phenobarbital 760.77 phenytoin 760.77 pravastatin 760.78 progestins 760.79 retinoic acid 760.78 simvastatin 760.78 solvents 760.79 specified agent NEC 760.79 statins 760.78 suspected, affecting management of pregnancy 655.5 tetracycline 760.74 thalidomide 760.79 trimethadione 760.77 valproate 760.77 valproic acid 760.77 vitamin A 760.78 Transmission of chemical substances through the placenta (affecting fetus or newborn) 760.70 alcohol 760.71 anticonvulsants 760.77 antifungals 760.74 anti-infective agents 760.74 antimetabolics 760.78 cocaine 760.75 "crack" 760.75 diethylstilbestrol [DES] 760.76 hallucinogenic agents 760.73 medicinal agents NEC 760.79 narcotics 760.72 obstetric anesthetic or analgesic drug 763.5 specified agent NEC 760.79 suspected, affecting management of pregnancy 655.5